7b The pharmacological prevention of pre-eclampsia

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Best Practice & Research in Clinical Obstetrics & Gynaecology

• Publication date

  1995-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0950-3552(05)80378-5
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of nitric oxide in the pathogenesis of preeclampsia.

  1994cited by this paper
• LIPID PEROXIDATION IN PREGNANCY

  1994cited by this paper
• Neonatal platelet reactivity and serum thromboxane B2production in whole blood: the effect of maternal low dose aspirin

  1994cited by this paper
• CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women

  1994cited by this paper
• Aspirin as an antiplatelet drug.

  1994cited by this paper
• A nitric oxide donor improves uterine artery diastolic blood flow in normal early pregnancy and in women at high risk of pre‐eclampsia

  1994cited by this paper
• Prenatal determination of fetal RhD type.

  1994cited by this paper
• Urinary dipstick protein: a poor predictor of absent or severe proteinuria.

  1994cited by this paper
• Relationship Between Nitric Oxide Synthesis and Increase in Systolic Blood Pressure in Women with Hypertension in Pregnancy

  1993cited by this paper
• NO is more important than PGI2 in maintaining low vascular tone in feto-placental vessels.

  1993cited by this paper
• Combined effect of the 5-HT2 receptor antagonist DV-7028 and aspirin or heparin on coronary cyclic flow reductions in dogs.

  1993cited by this paper
• Endothelial vasoactive mediators in preeclampsia.

  1993cited by this paper
• Low-dose aspirin therapy to prevent preeclampsia.

  1993cited by this paper
• The effect of low-dose aspirin on umbilical artery Doppler measurements.

  1993cited by this paper
• Effects of Maternal Ingestion of Low-Dose Aspirin on the Fetal Cardiovascular System

  1993cited by this paper
• Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event.

  1993cited by this paper
• The effect of low-dose aspirin on fetal urine output and amniotic fluid volume.

  1993cited by this paper
• Prevention of preeclampsia with low‐dose aspirin in healthy, nulliparous pregnant women

  1993cited by this paper
• Platelet-poor plasma serotonin in normal and preeclamptic pregnancy.

  1993cited by this paper
• Aspirin in pregnancy.

  1993cited by this paper
• Prostacyclin agonists reduce early atherosclerosis in hyperlipidemic hamsters. Octimibate and BMY 42393 suppress monocyte chemotaxis, macrophage cholesteryl ester accumulation, scavenger receptor activity, and tumor necrosis factor production.

  1993cited by this paper
• Aspirin does not inhibit adenosine diphosphate-induced platelet alpha- granule release

  1993cited by this paper
• Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension

  1993cited by this paper
• The effect of low dose aspirin on bleeding times

  1993cited by this paper
• Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia.

  1993cited by this paper
• Low‐dose aspirin in the prevention of preeclampsia and fetal growth retardation: Rationale, mechanisms, and clinical trials

  1993cited by this paper
• Attenuation of the vasoconstrictor effects of thromboxane and endothelin by nitric oxide in the human fetal-placental circulation.

  1992cited by this paper
• Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean

  1992cited by this paper
• Estrogen-induced uterine vasodilatation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis.

  1992cited by this paper
• Platelet activation and vascular damage in gestational hypertension

  1992cited by this paper
• Pathogenesis of preeclampsia: a hypothesis.

  1992cited by this paper
• Low-dose aspirin inhibits lipid peroxides and thromboxane but not prostacyclin in pregnant women.

  1992cited by this paper
• Aspirin in pregnancy

  1992cited by this paper
• A randomized placebo‐controlled study of the effect of low dose aspirin on platelet reactivity and serum thromboxane B2 production in non‐pregnant women, in normal pregnancy, and in gestational hypertension

  1992cited by this paper
• Early detection of preeclampsia.

  1991cited by this paper
• Animal models of opiate, cocaine, and cannabis use.

  1991cited by this paper
• Endothelial cell activation as a pathogenetic factor in preeclampsia.

  1991cited by this paper
• Endothelium-dependent relaxation, endothelium-derived relaxing factor and photorelaxation of blood vessels.

  1991cited by this paper
• Fetal Platelet Consumption: A Feature of Placental Insufficiency

  1991cited by this paper
• Physiological significance of endogenous nitric oxide.

  1991cited by this paper
• The renin-angiotensin-aldosterone system in preeclampsia. A review.

  1991cited by this paper
• Endothelial-derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension.

  1991cited by this paper
• Nitric oxide: an endogenous modulator of leukocyte adhesion.

  1991cited by this paper
• Effect of low-dose aspirin on vascular refractoriness in angiotensin-sensitive primigravid women.

  1991cited by this paper
• Thromboxane A2 synthesis in pregnancy‐induced hypertension

  1991cited by this paper
• Differential inhibition of vascular prostacyclin and platelet thromboxane synthesis by different doses aspirin and by the thromboxane inhibition ridogrel (R 68070)

  1991cited by this paper
• Drugs in Pregnancy and Lactation

  1990cited by this paper
• Low‐dose aspirin in pregnancy

  1990cited by this paper
• Regulatory functions of the vascular endothelium.

  1990cited by this paper
• Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertension.

  1990cited by this paper
• Review: The use of aspirin in pregnancy

  1990cited by this paper
• Increased plasma levels of ED1+ cellular fibronectin precede the clinical signs of preeclampsia.

  1990cited by this paper
• Platelets and the beginnings of preeclampsia.

  1990cited by this paper
• Preeclampsia: an endothelial cell disorder.

  1989cited by this paper
• R 68 070: Thromboxane A2 Synthetase Inhibition and Thromboxane A2/Prostaglandin Endoperoxide Receptor Blockade Combined in One Molecule - I. Biochemical Profile In Vitro

  1989cited by this paper
• Prediction and prevention of pregnancy-induced hypertensive disorders : a clinical and pathophysiologic study

  1989cited by this paper
• Predictive value of increased plasma levels of fibronectin in gestational hypertension

  1989cited by this paper
• Placental-type plasminogen activator inhibitor in preeclampsia.

  1988cited by this paper
• Preeclampsia: a review of the role of prostaglandins.

  1988cited by this paper
• Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension.

  1987cited by this paper
• Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

  1987cited by this paper
• ASPIRIN ACETYLATES FIBRINOGEN AND ENHANCES FIBRINOLYSIS IN VIVO. FIBRINOLYTIC EFFECT IS INDEPENDENT OF CHANGES IN PLASMINOGEN ACTIVATOR LEVELS

  1987cited by this paper
• Hemostasis and thrombosis: Basic principles and clinical practice

  1987cited by this paper
• Effect of low-dose aspirin on angiotensin II pressor response in human pregnancy.

  1987cited by this paper
• Low dose aspirin treatment in late pregnancy differentially inhibits cyclo-oxygenase in maternal platelets.

  1987cited by this paper
• Predictive value of fibronectin levels in normotensive gravid women destined to become preeclamptic.

  1986cited by this paper
• Prevention of pre-eclampsia by early antiplatelet therapy.

  1985cited by this paper
• Preeclampsia: an imbalance in placental prostacyclin and thromboxane production.

  1985cited by this paper
• First use of nafazatrom, a new antithrombotic drug, in pregnancy.

  1984cited by this paper
• Preliminary observations on treatment of pregnancy-induced hypertension with a thromboxane synthetase inhibitor.

  1984cited by this paper
• Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase.

  1984cited by this paper
• Causes of perinatal death associated with gestational hypertension and proteinuria.

  1979cited by this paper
• Effect of aspirin on incidence of pre-eclampsia.

  1979cited by this paper
• Pregnancy hypertension : a systematic evaluation of clinical diagnostic criteria

  1977cited by this paper
• Perinatal mortality and birth-weight in relation to aspirin taken during pregnancy.

  1976cited by this paper

• Pathophysiology and Medical Management of Systemic Hypertension in Pregnancy

  2005cites this paper
• The herbal medicine Toki-shakuyaku-san improves the hypertension and intrauterine growth retardation in preeclampsia rats induced by Nomega-nitro-L-arginine methyl ester.

  2004cites this paper
• Hemodynamic responses of broiler pulmonary vasculature to intravenously infused serotonin.

  2002cites this paper
• Prevention of pre-eclampsia: status and perspectives 2000.

  2001cites this paper
• Prediction and prevention of pregnancy-induced hypertensive disorders.

  1999cites this paper
• Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre‐eclampsia and its complications

  1998cites this paper
• Randomised controlled trial of ketanserin and aspirin in prevention of pre-eclampsia.

  1997cites this paper
• Endothelial dysfunction in preeclampsia. Part I: Primary prevention. Therapeutic perspectives.

  1996cites this paper